Pneumonia

>

Latest News

 Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates / image credit ©Kateryna_Kon/stock.adobe.com
Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates

April 2nd 2025

A mail campaign targeting adults with chronic conditions as well as their GPs increased the number receiving at least 1 shot by 9.5 percentage points.

Sanofi and SK Bioscience Expand Pneumococcal Vaccine Partnership, Launch Phase 3 Trial for PCV21 / Image credit: ©Crystal Light/AdobeStock
Sanofi and SK Bioscience Expand Pneumococcal Vaccine Partnership, Launch Phase 3 Trial for PCV21

January 6th 2025

Pneumococcal 21-Valent Conjugate Vaccine in At-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock
Pneumococcal 21-Valent Conjugate Vaccine in At-Risk Adults: Daily Dose

October 30th 2024

ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 Years / image credit  ©CDC
ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 from 65 Years

October 24th 2024

ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults / Image credit: ©Crystal Light/AdobeStock
ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults

September 20th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.